Funding for this research was provided by:
Hunter Medical Research Institute (HMRI 780, HMRI 1096, HMRI 1357)
Received: 12 August 2021
Accepted: 14 January 2022
First Online: 25 January 2022
: The murine median survival study was reviewed, approved, and performed in accordance with the with the Northern Sydney Local Heath District Animal Ethics Committee guidelines, Royal North Shore Hospital, St Leonards, Australia (Approval #RESP/17/205) which enforces the New South Wales Animal Research Act 1985.
: Not applicable.
: KM, AH, HD, SS, HW and VH declare no conflicts of interest. CD has received speaker honoraria from Merck, and participation on advisory boards for Ipsen and Amgen.